A carregar...
Does it help that efficacy has been proven once we start discussing (added) benefit?
Since the introduction of benefit assessment to support reimbursement decisions in Germany there seems to be the impression that totally distinct methodology and strategies for decision making would apply in the field of drug licensing and reimbursement. In this article, the position is held that, w...
Na minha lista:
| Publicado no: | Biom J |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4758384/ https://ncbi.nlm.nih.gov/pubmed/26140608 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/bimj.201400017 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|